Rare Disease: Sustained Progress In Development Regardless Of The Pandemic - Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com. Sunday, February 28, 2021, was Rare Disease Day. With so much focus on COVID-19 throughout 2020, it's important to recognize the continued work done in rare disease drug development by sponsors and FDA throughout 2020. In addition, a number of policies implemented in response to COVID-19 are expected to have a positive impact on rare disease drug development going forward. Yet, the lasting nature of these policies, post-pandemic, remains uncertain, creating an opportunity for rare disease d...